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214 Abstract
15 Purpose
16 To test the prebiotic activity of wheat arabinogalactan-peptide (AGP), which is a soluble dietary 
17 fibre composed of arabinogalactan polysaccharide linked to a 15-residue peptide, which 
18 accounts for up to 0.4% of the dry weight of wheat flour. 
19 Methods
20 The prebiotic activity of AGP prepared from white wheat flour was tested using in-vitro 
21 fermentation by colonic bacteria in automated pH controlled anaerobic stirred batch cultures 
22 and compared to fructooligosaccharide (FOS) and wheat flour arabinoxylan (AX). Bacterial 
23 populations were measured using fluorescence in-situ hybridisation (flow-FISH) and short-
24 chain fatty acid (SCFA) concentrations were measured using HPLC.
25 Results
26 Fermentation of AGP resulted in a significant bifidogenic activity and increased concentrations 
27 of SCFAs, mainly acetate after 24 h of fermentation.
28 Conclusions
29 These results were comparable to those obtained with AX and confirm the prebiotic potential 
30 of AGP. Furthermore, fermentation of a mixture of AGP and AX was faster compared to the 
31 single substrates and more similar to FOS, indicating that combinations of fermentable 
32 carbohydrates with different structures are potentially more effective as prebiotics than single 
33 substrates. 
34
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342 Introduction
43 Cereals are the most important source of dietary fibre (DF) in the human diet, providing about 
44 40% of the total dietary intake in the UK, with bread contributing about half of this.
45 A number of definitions of dietary fibre have been proposed, the most widely used being that 
46 from the Codex Alimentarius 2009 which states that “dietary fibre consists of carbohydrate 
47 polymers with 10 or more monomeric units, which are not hydrolysed by the endogenous 
48 enzymes in the small intestine”. However, a footnote allows national authorities to also include 
49 “carbohydrates of 3 to 9 monomeric units” and these are usually included when considering 
50 wheat fibre. A number of studies have demonstrated that DF, and particularly cereal DF, has 
51 health benefits including regulation of satiety and diluting the energy density of food. The 
52 addition of insoluble DF to the diet increases stool weight from fibre bulk and increases in 
53 bacteria and water holding capacity. Soluble DF has also been shown to reduce the glycaemic 
54 index of food products, reduce insulin sensitivity and decrease cholesterol absorption. 
55 Furthermore, DF has also been shown to reduce the risk of colorectal cancer.
56 While whole wheat grain contains 11.5-15.5 % total DF, the content is much lower in the white 
57 flour which is used to make most food products and comprises the starchy endosperm but not 
58 the fibre-rich aleurone and outer layers of the grain. The major DF components in wheat are 
59 cell wall polysaccharides, which account for about 2-3% of the dry weight (comprising about 
60 70% arabinoxylan (AX), 20% (1→3,1→4)-β-D-glucan (β-glucan), 2% cellulose ((1→4)-β-D-
61 glucan) and 7% glucomannan [1] and 1.4-1.7% fructo-oligosaccharides (fructans) [2].In 
62 addition, white wheat flour contains up to 0.4 % dry weight of arabinogalactan-peptide (AGP) 
63 [3,4] which comprises a 15-residue amino acid peptide [5] including three hydroxyprolines 
64 which are o-glycosylated with branched arabinogalactan chains [6]. In most plants, 
65 arabinogalactans occur in covalent association with protein, either as proteoglycans or as 
66 glycoproteins, however in wheat AGP, the polysaccharide is estimated to account for about 
67 90% of the molecular mass. Although a recent study indicates that AGP is located in the 
68 cytoplasm or vacuole of the wheat cell, it does not appear to be essential for grain development 
69 and little is known of its biological function [7] or impact on human nutrition and health.
70 The process of fermentation, where colonic microbiota break down carbohydrates to 
71 monosaccharides before metabolising them to short chain fatty acids (SCFAs) appears to be 
72 particularly important to health benefits of DF. These benefits have led to the concept of 
73 “prebiotics”: substrates that are selectively utilized by host microorganisms conferring a health 
74 benefit [8]. Prebiotics can also alter the host colonic microbiota to a more favourable 
75 composition, for example by increasing the proportions of beneficial bacteria (e.g. 
76 bifidobacteria and/or lactobacilli) [9].
477 Cereal DF components, particularly β-glucan and fructans, have well-established prebiotic 
78 activity, while a number of studies have demonstrated prebiotic activity for wheat AX [10–13].   
79 However, although the concentration of AGP in wheat flour is similar to those of water-soluble 
80 AX and total β-glucan, its prebiotic potential has not been determined. We have therefore 
81 evaluated the prebiotic properties of AGP and determined whether AGP behaves 
82 synergistically with soluble AX from wheat flour, using an in vitro faecal culture system. 
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84 Materials and methods
85 Materials. AGP and water-soluble AX (average DP 131 (obtained using HP-SEC-MALLS 
86 using OHpak SB 802.5 HQ column on an Agilent 1260 infinity LC system)) were prepared 
87 from white flour from the wheat cultivar Yumai 34 using the method from Loosveld et al. [3] 
88 Fructo-oligosaccharides (FOS) from chicory (F8052 Sigma) (average DP 2-8) was used as a 
89 standard.
90 Monosaccharide analysis. Fifty µL of a solution of 1mg/mL AX was dried under vacuum to 
91 which was added 400 μL of 2M trifluoracetic acid (TFA) and incubated at 120°C for 1 h in a 
92 heating block to hydrolyse samples. Hydrolysed samples were cooled on ice and dried in 
93 speed-vac at 30°C (overnight). 500μL of water was added to remove any remaining TFA and 
94 the sample was dried again in the speed-vac. The sample was finally resuspended in 400 μL 
95 of MilliQ water. The hydrolysate was diluted further 1:1 with water. Standard curves were 
96 constructed for fucose, rhamnose, arabinose, galactose, glucose, xylose, mannose, 
97 galacturonic acid, and glucuronic acid using monosaccharide standards prepared from stock 
98 solutions of 1 mM and subjecting them to the same acid-hydrolysis protocol as for samples. 
99 All samples and standards were run under the same conditions as described below. Twenty 
100 μL was injected onto a Carbopac PA20 column with flow rate 0.5 mL/min and gradient: 
101 isocratic 4.5 mM KOH, 0-13 min; linear 4.5 to 10 mM KOH, 13-14 min; linear 10 to 13 mM 
102 KOH, 14-15 min; linear 13 to 20 mM, 15-16 min; isocratic 20 mM 16-17 min; linear 20 to 4.5 
103 mM KOH, 17 -18 min followed by isocratic 4.5 mM KOH 18 -23 min; on a Dionex 5000 Ion 
104 Chromatography HPLC equipped with disposable gold electrode.
105 MALDI-ToF-MS. MALDI-ToF-MS was as described in Marsh et al. [14] using a Micromass 
106 MALDI-LR mass spectrometer (Waters, Manchester, U.K.). 
107 In-vitro fermentation. 100-mL sterile batch fermentation vessels (50 mL working volume) 
108 were aseptically filled with 45 mL of sterile basal medium and sparged with O2- free N2 
109 overnight to establish anaerobic conditions. The medium contained per litre: 2 g of peptone 
110 water (Oxoid Ltd., Basingstoke, United Kingdom), 2 g of yeast extract (Oxoid), 0.1 g of NaCl, 
111 0.04 g of K2HPO4, 0.01 g of MgSO4.7H2O, 0.01 g of CaCl2. 6H2O, 2 g of NaHCO3, 0.005 g of 
112 hemin (Sigma), 0.5 g of l-cysteine HCl (Sigma), 0.5 g of bile salts (Oxoid), 2 mL of Tween 80, 
113 10 µL of vitamin K (Sigma). Polysaccharide samples were added (1% w/v) to the basal 
114 medium. Each vessel was inoculated with 10% (v/v) of faecal slurry from a single donor, which 
115 was prepared by homogenizing fresh human faeces (10%, w/w) in phosphate-buffered saline 
116 (PBS; 8 g/L NaCl, 0.2 g/L KCl, 1.15 g/L Na2HPO4, and 0.2 g/L KH2HPO4), pH 7.3 (Oxoid), 
117 using a stomacher (Stomacher 400, Seward). Three non-pooled faecal donors were used per 
6118 experiment, two male and one female, between 23-59 years of age and on a normal diet 
119 without any special dietary requirements and that had not taken antibiotics, prebiotic or 
120 probiotics in the previous three months. Two experiments were run due to limitations of vessel 
121 numbers, one with a negative control (no carbon source added), FOS (0.5g) (positive control), 
122 AGP (0.5g) and AGP+AX (0.25g and 0.25g), and the second with a negative control, positive 
123 control as before and AX (0.5g). Vessels were incubated at 37°C with a water jacket for up to 
124 48h and the pH was controlled between 6.7 and 6.9 using an automated pH controller with 
125 0.5M HCL and NaOH (Fermac 260, Electrolab, Tewkesbury, UK). Samples 2x 1mL were 
126 collected at 0, 8 and 24 hours for analysis. 
127 SCFA analysis using HPLC. Aliquots of 750 µL were removed from in vitro fermentation 
128 vessels and centrifuged at 13000 x g for 5 minutes to remove particulate matter and filtered 
129 using a 0.2μM nitrocellulose filter. 20 μL was injected on to a Rezex ROA Organic Acid H+ 
130 (8%) HPLC column (Phenomenex, UK) at 50°C on a Shimadzu Prominence HPLC with 0.0025 
131 M H2SO4 eluent at a flow rate of 0.6 mL min-1. SCFA (lactate, formate acetate, propionate and 
132 butyrate) were quantified with reference to calibration curves from 5-50mM of authentic 
133 standards (Sigma).
134 Enumeration of bacteria by flow-FISH. Samples of 750µL removed from in vitro 
135 fermentation vessels were immediately placed on ice, before centrifugation at 13000 x g for 3 
136 min and the supernatant discarded. Pelleted bacteria were fixed for 4h at 4 °C in (PBS) and 
137 4% (w/v) filtered paraformaldehyde (PFA) (Sigma-Aldrich P6148, pH 7.2) in a ratio of 1:3 (v/v). 
138 Samples were washed twice with filtered PBS and resuspended in 600 μL of a mixture of 
139 PBS/ethanol (1:1, v/v) and then stored at −20 °C for up to 3 months. Hybridisation was carried 
140 out as described in Rycroft et al. [15,16] using genus and group specific 16S rRNA-targeted 
141 oligonucleotide probes (MWG Biotech, Ebersberg, Germany). 
142 The sample probes used were Bif164 [17], Bac303 [18], Lab158 [19], Ato291 [20], Prop853 
143 [21], Erec482 [22], Rrec584 [21], Fprau655 [23], Chis150 [22], shown in Supplementary Table 
144 1. Samples were screened using a flow cytometer (Accuri C6, BD Biosciences, USA) with 
145 Accuri CFlow software. 
146 Statistical analysis. The Genstat (2015, 18th edition, © VSN International Ltd, Hemel 
147 Hempstead, UK) statistical package was used for all analysis. One-way analysis of variance 
148 (ANOVA) and F-test were applied to determine differences between treatments. Differences 
149 were deemed significant when P<0.05.
150 Results
7151 Monosaccharide analysis. Monosaccharide analysis of the AGP prepared from white flour 
152 (Triticum aestivum cv. Yumai 34) indicated that arabinose and galactose together comprised 
153 96.73% (±0.18) of total monosaccharides, with small amounts of glucose (2.6%) and xylose 
154 (1.74%). The A: G ratio for AGP was 0.48. The combined contents of arabinose and xylose in 
155 the arabinoxylan fraction prepared from the same flour were 91% (±0.05), with galactose (5%) 
156 and glucose (4%). The A:X ratio for AX was 0.62. These data indicate that the AGP and AX 
157 fractions were over 95% and over 90% pure, respectively.
158 MALDI-TOF-MS was used to confirm the structure and purity of the carbohydrate moiety of 
159 the AGP, based on the molecular masses of the oligosaccharides released by the exo-b-(1-
160 >3)-galactanase. All samples were permethylated as described in Tryfona et al. [6] based on 
161 Ciucanu and Kerek [24] prior to mass spectrometry. Figure 2 shows the spectrum from 400-
162 2400 m/z; the oligosaccharide composition is indicated by Hex (hexose residues) or Pent 
163 (pentose residues) while the subscript indicates the number of residues present, if greater 
164 than 1. The dominant ion was ‘Hex2 Pent’, at 637.5 m/z which is predicted to be two galactose 
165 units and an arabinose unit. The other ions are predicted as follows: m/z 477.7, Hex2; 841.5, 
166 Hex3Pent; 1001.6, Hex3Pent2; 1161.6, Hex3Pent3; 1365.8, Hex4Pent3; 1730.0, Hex5Pent4; 
167 1934.0, Hex6Pent4; 2095.2, Hex6Pent5.  
168 Effect of fermentation on SCFA concentrations. The concentrations of SCFA and lactate 
169 after fermentation of AGP were compared with the negative control (no substrate), FOS 
170 (positive control) and AX in Table 1. Significant increases (p<0.05) compared to the negative 
171 control, occurred in the concentrations of total SCFAs for all substrates, which mainly resulted 
172 from increased acetic acid. Acetic acid concentrations increased after 8h fermentation of all 
173 substrates, with FOS having the greatest increase. Acetate continued to increase until 24h 
174 fermentation for all substrates, however, at 24h the greatest increase in acetate was by 
175 fermentation of AGP (39.34 mM) and AGP+AX (38.91 mM). Large decreases occurred in 
176 lactate concentrations with the AGP, AGP+AX and AX substrates after 24h compared with 
177 their negative controls. Total SCFA concentrations after 24h fermentation were all significant 
178 and similar, the highest being with FOS (72.36mM), then in order of decreasing concentration, 
179 AGP+AX (67.42mM), AGP (61.95mM) and AX (57.15mM). Although the 1:1 mixture of AX and 
180 AGP resulted in higher concentrations of total SCFAs than either single substrate, these 
181 increases were not statistically different.
182 Effect of fermentation on bacterial populations. The populations of the dominant types of 
183 human colonic bacteria are shown in Table 2, while the populations of total enumerated 
184 bacteria, Bifidobacterium and Clostridium coccoides/Eubacteium rectale are shown in Figure 
185 3. The Bifidobacterium populations increased significantly (p<0.05) compared to the negative 
8186 control after 8h fermentation for FOS (positive control) and AGP+AX with the greatest increase 
187 of 1.95 log occurring with fermentation of FOS, followed by an increase of 1.37 log with 
188 AGP+AX. The populations of Bifidobacterium increased with the separate AX and AGP 
189 substrates between 8-24h but decreased 0.88 log between 8-24h for FOS and 0.53 log for 
190 AGP+AX. As with Bifidobacterium, the Clostridium coccoides- Eubacterium rectale group 
191 increased after 8h fermentation of FOS and AGP+AX, and after 24h fermentation of AX and 
192 AGP.  No significant changes were observed in the Lactobacillus Enterococcus group, 
193 Bacteroides-Prevotella group, Roseburia, Atopobium, Desulfovibrionales, Clostridium cluster 
194 IX, Faecalibacterium prausnitzii group or Clostridium-cluster I and II.  The 1:1 mixture of AGP 
195 and AX gave significantly greater populations of the beneficial Bifidobacterium and Clostridium 
196 coccoides/ Eubacterium rectale groups than either single substrate at 8 hours, but these were 
197 lower at 24 hours. 
9198 Discussion
199 This study aimed to determine the prebiotic potential of the soluble wheat fibre AGP. AGP 
200 isolated from wheat flour was characterised and evaluated for prebiotic activity based on 
201 increases in the populations of beneficial bacteria and in the production of SCFA, using in vitro 
202 batch cultures. The fermentation of AGP was also compared to FOS and AX, which have 
203 established prebiotic activity [10,11,25,26], in addition, a mixture of AGP and AX was tested 
204 to determine whether the combination may result in a synergistic prebiotic effect.
205 Short-chain fatty acids (SCFA) are volatile fatty acids consisting of a straight-chain, aliphatic 
206 tail of fewer than six carbon atoms and are produced by fermentation of oligosaccharide 
207 concomitant with increases in beneficial bacteria including Bifidobacterium. The principal 
208 SCFAs are acetate, propionate and butyrate, together comprising 95% of all SCFAs produced 
209 [27] and are metabolized primarily by the colonic epithelium (butyrate), liver (propionate) and 
210 muscle (acetate) [28]. The concentrations of SCFAs in this study were used as a measure of 
211 the rate of fermentation of the substrates, with significant increases particularly apparent in 
212 the predominant SCFA, acetate. The spectra in Figure 2 are very similar to those reported for 
213 AGP from white flour of cv. Cadenza by Tryfona et al. [6]. The mass spectra therefore confirm 
214 the purity and identity of the AGP used for in vitro fermentation.
215 Despite the huge variety of different bacterial populations present in the gut and relatively low 
216 numbers of the bacterial genus Bifidobacterium in the healthy adult(<5%) [29] this genus is 
217 most often targeted by prebiotics. This is because of  it’s association with multiple health 
218 benefits, including reducing the proliferation of colorectal cancer and the concentration of 
219 circulating cholesterol [30,31]. A decrease Bifidobacterium levels below those in healthy adults 
220 has been linked to disorders such as antibiotic-associated diarrhoea, inflammatory bowel 
221 disease, irritable bowel syndrome, obesity and allergies [32] demonstrating their importance 
222 in the colon despite relatively low numbers. In this study, all substrates demonstrated 
223 beneficial effects by significantly increasing (p<0.05) the populations of Bifidobacterium from 
224 8h to 24h compared to the negative control (Table 2 and Figure 3). Unlike the FOS and 
225 AGP+AX mixture which showed the maximum Bifidobacterium growth at 8h, proliferation was 
226 slower with AGP and AX singly as substrates, reaching the greatest population numbers after 
227 24h. This effect was observed with all donors in the study, therefore it appears to show that 
228 bifidobacteria ferment soluble wheat flour AX and AGP more slowly than FOS. The same 
229 effect was observed with the populations of the predominant beneficial bacterial group [33] 
230 Clostridium coccoides/ Eubacterium rectale (Clostridium Cluster XIVa and XIVb), which 
231 showed significant increases simultaneously with  bifidogenic effects and may be indicative of 
232 cross feeding interactions as reported by Riveire et al., (2015). 
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233 The structures of fermentable carbohydrates, including the degree of polymerisation (DP) and 
234 molecular weight have previously been shown to affect the rate of fermentation [26] and FOS 
235 is thought to be rapidly fermented due to its low DP [34]. In this study, the DP of the AX 
236 (average DP 131) was much greater than that of FOS (DP 2-8). The longer polysaccharides 
237 in AX have fewer non-reducing ends per unit mass than FOS, providing less substrate for 
238 hydrolysis by bacterial enzymes, which may have contributed to the slower rate of 
239 fermentation shown with AX. Wheat AGP is considered have three carbohydrate moieties. 
240 Their molecular masses have not been determined but estimates of between 122- 389 sugar 
241 residues can be made based on the reported mass of the whole AGP molecule, ranging from 
242 22,000 to 70,000. [4,35–37]. This mass is much greater than that of FOS, accounting for the 
243 slower fermentation.
244 A slower rate can be advantageous for health as it allows the prebiotic to reach the more distal 
245 regions of the colon, where the levels of fermentable carbohydrate are lower, and fermentation 
246 of proteins occurs with adverse effects [38].
247 The combination of AX+AGP showed faster fermentation than either substrate singly, with 
248 significant increases in beneficial bacterial populations by 8h fermentation, similar to that of 
249 FOS. 
250 It is possible that a faster fermentation may be achieved via utilization of multiple non-
251 competing bacterial enzymes. For example some Bacteroides spp. have been found to fully 
252 ferment highly branched xylans as well as β1-3 and β1-4 arabinogalactans from soy by 
253 producing multiple enzymes [39].
254 Desulfovibrionales (DSV) is a group of sulphate-reducing bacteria which are suggested to 
255 contribute to the development of ulcerative colitis through the production of cytotoxic H2S and 
256 add to the pathology of the disease [40], [41] (although this role is disputed as analyses of 
257 bacterial populations from faeces and mucosal biopsies have so far failed to demonstrate 
258 changes in DSV populations associated with the disease) [42].  Similarly, bacteria of 
259 Clostridium cluster I and II are also considered to have adverse effects on health, as they are 
260 associated with protein fermentation and some end products of protein fermentation can be 
261 harmful to the host e.g. amines and ammonia [43]. A shift to protein fermentation has been 
262 linked with increases in diseases such as irritable bowel syndrome (IBS) and colonic cancers, 
263 which occur more often in the distal regions of the gut [43,44]. The populations of 
264 Desulfovibrionales, and Clostridium-cluster I and II did not increase with any of the substrates, 
265 despite the presence of a peptide chain in the AGP. This could be due to competition from 
266 saccharolytic bacteria which were still increasing up to 24h of fermentation, to the low 
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267 proportion of the peptide in the AGP structure 8% [45] or to the inaccessibility of the peptide, 
268 surrounded by arabinogalactan [45]. 
269 Total SCFA concentrations were highest with the positive control (FOS) after 24h and 
270 comprised mostly acetate. The second highest concentration of total SCFAs was generated 
271 by AGP+AX combined, being higher than those resulting from fermentation of either single 
272 component and comprised mainly acetate and propionate. The most abundant SCFAs, 
273 acetate, propionate and butyrate, have been shown to have multiple beneficial effects for the 
274 host, for example, by providing dietary energy, and by suppressing the growth of pathogens 
275 by decreasing the pH of the intestinal lumen [46]. These SCFAs were also reported to have 
276 anti-inflammatory effects in rats [47] and influence intestinal motility in rats via G-protein 
277 coupled receptor activation, with acetate being the most effective, followed by propionate and 
278 butyrate [48]. The production pathways of acetate are found widely among bacterial groups, 
279 however pathways for production of propionate, butyrate and lactate appear more highly 
280 conserved and substrate specific. [49]
281 Large increases in acetate were observed after fermentation of all substrates, with AGP and 
282 AGP+AX showing the greatest increases. Bifidobacteria are known to produce acetate [50,51] 
283 and were observed to increase concomitantly with acetate concentration with all substrates, 
284 however (as Actinobacteria) they are present in much smaller numbers than bacteria from the 
285 Bacteroides and Firmicutes phyla.  Acetate production occurs via widely distributed pathways 
286 among bacterial groups so the increases in acetate can also be attributed to other bacteria, 
287 including the predominant group found in the gut which can also produce acetate, the 
288 Clostridium coccoides group [33,52] which increased in all substrates. Pathways for 
289 propionate, butyrate and lactate production appear more highly conserved and substrate 
290 specific [49]. The decreases in lactate observed during fermentation of AGP, AGP+AX and 
291 AX demonstrate a healthy colonic environment and bacterial cross feeding. Under healthy gut 
292 conditions lactate is only present in low concentrations in faeces (<5mM) [53] because 
293 bacterial breakdown markedly exceeds production [54]. Lactate is formed from pyruvate 
294 through the action of lactate dehydrogenase in the homofermentative pathway by many 
295 common gut bacteria including Lactobacillus, Bifidobacterium, Enterococcus, and 
296 Streptococcus and Eubacterium spp. [55] but can also be converted to other SCFA. 
297 Decreases in lactate can therefore represent cross-feeding of different bacterial species  
298 including the species Roseburia intestinalis, Eubacterium rectale, Eubacterium halii and 
299 Anaerostipes caccae[53,54,56,57] which utilise lactate for production of other SCFAs-mainly 
300 butyrate but also propionate and valerate [56]. Because this mechanism is widely utilised it is 
301 not possible to attribute the decreases in lactate to specific bacterial groups in this study, 
302 however, the large decreases in lactate shown by fermentation of both AGP and AGP+AX 
12
303 demonstrates a greater proportion of lactate-utilizing than lactate-producing bacteria which is 
304 important as an accumulation of lactate in the gut can cause acidosis, neurotoxicity, and 
305 cardiac arrhythmia [58]. Lactate levels were not observed to drop over time with fermentation 
306 of FOS, which remained similar to the negative control, however this was due to large 
307 individual variations (Table S1)
308 Butyrate is produced by a range of bacteria, including the Clostridium, Roseburia and 
309 Eubacterium genera [51] but is dominated by Faecalibacterium prausnitzii, Eubacterium 
310 rectale, Eubacterium hallii and R. bromii [62]. No significant increases in butyrate were 
311 observed with fermentation of any of the substrates in this study (although FOS gave a non-
312 significant increase by 24h). It is thought that wheat polysaccharides, which would include, AX 
313 and AGP, are not directly butyrogenic but rely on cross-feeding interactions between bacteria 
314 that utilize metabolites to produce butyrate and those producing the precursor metabolites 
315 directly from fermentation (e.g. Eubacterium spp., Faecalibacterium prausnitzii, and Roseburia 
316 which can utilize acetate from bifidobacteria) [58]. The butyrate concentration has previously 
317 been shown to increase during in vitro fermentation of several commercially available samples 
318 of wheat AX [23], however this effect was not observed in this study and may be due to a lack 
319 of the dominant butyrate producers Faecalibacterium prausnitzii, [62] which did not increase 
320 during fermentation.
321 Wheat AGP showed potential prebiotic activity during in vitro fermentation, by selectively 
322 increasing populations of beneficial bacteria including Bifidobacterium and Eubacterium 
323 genera and providing increases in the concentration of SCFAs (mainly consisting of acetate). 
324 A slower fermentation can demonstrate that a substrate is able to persist to more distal regions 
325 of the colon. AGP showed slower bacterial fermentation than FOS, however, this persistence 
326 is unlikely to occur when wheat products are consumed as combining AGP with AX resulted 
327 in faster utilisation of the substrates. Since the ratio of water-soluble AX to AGP used in these 
328 experiments is similar to that in white wheat flour, their potential to act synergistically is more 
329 relevant to the consumption of wheat products than the results obtained with single substrates. 
330 This study used faecal samples to provide microbial populations for fermentation in vitro. The 
331 results should therefore be confirmed with larger numbers of samples and an in vivo human 
332 intervention study to further clarify the role of AGP/AGP+AX in colonic fermentation.’
333 The manuscript does not contain clinical studies or patient data. On behalf of all authors, the 
334 corresponding author states that there is no conflict of interest.
335
336
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594 Figure 1 Monosaccharide analysis of extracted AGP and AX using a Carbopac PA20 column 
595 (N=3). Error bars are SD
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601 Figure 2 MALDI-ToF MS spectra showing ions of m/z diagnostic of per-methylated 
602 oligosaccharides released from AGP by exo-B-(1->3) galactanase digestion. AGP was 
603 isolated from Triticum aestivum cv. Yumai-34 white flour. Spectra shows 400-2400 m/z
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Figure 3 Total bacteria, Bifidobacterium and 
Clostridium coccoides/ Eubacterium rectale 
populations after fermentation of different substrates 
at times 0,8, and 24 h analysed by Flow-FISH. Error 
bars show SEM (n=3). Significant differences (p<0.05) 
from negative control are denoted with  *
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608 Figure 4 Proportional abundance of bacterial groups over the course of 24h fermentation. 
609 Data represent the mean of three independent fermentation
610
22
611
612 Table 1 SCFA and lactate concentration in batch cultures at 0, 4, 8 and 24 hours’ 
613 fermentation comparing no substrate, FOS, AGP and AX. Formate is included in total 
614 SCFA but not shown. One-way AVONA was applied to the data to test the main interaction 
615 between treatments. Significant interaction between treatments and negative control are 
616 denoted. Standard error of the mean (SEM) is shown in brackets. Significant differences 
617 between treatments and relevant negative control are denoted * p= 0.05 (F-test)
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2.22 
(0.50) 21.85 (3.15)
8 5.66 (0.44) 9.05 (2.40) 8.77 (1.42) 1.53 (0.36) 26.24 (3.97)
Negative control 
for AX
24 6.45 (0.16) 9.84 (2.71) 9.33 (1.85) 1.20 (0.22) 30.08 (1.97)
0 16.39 (3.37) 4.93 (1.01) 5.05 (0.60)
1.54 
(0.20) 27.91 (3.04)
8 10.19 (2.86)
21.12 (4.46) 
* 8.09 (0.48)
1.76 
(1.76) 47.79 (4.99) *AX
24 2.56 (1.31) *
27.64 (4.85) 
* 9.76 (2.77)
1.29 
(0.12)
57.15(12.25) 
*
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0 7.96 (0.26)
6.80 
(0.38)
7.14 
(0.031) 8.53 (0.33)
6.78 
(0.75)
7.20 
(0.58)
7.35 
(0.36)
8.28 
(0.25)
7.85 
(0.47)
6.86 
(0.40) 8.97 (0.33)
8 7.72 (0.11)
7.16 
(0.12) 7.43 (0.22) 8.37 (0.25)
7.38 
(0.02)
7.20 
(0.10)
7.42 
(0.27)
8.06 
(0.24)
7.69 
(0.30)
7.31 
(0.17) 8.85 (0.22)Negative
24 7.68 (0.66)
7.25 
(0.73) 7.36 (0.68) 8.00 (0.49)
7.46 
(0.71)
7.51 
(0.52)
7.53 
(0.60)
7.49 
(0.58)
7.38 
(0.46)
7.12 
(0.73) 8.62 (0.57)
0 7.88 (0.27)
7.01 
(0.46)
7.57 
(0.43) 8.23 (0.27)
7.41 
(0.50)
7.01 
(0.49)
7.45 
(0.35)
8.22 
(0.25)
7.75 
(0.46)
7.11 
(0.59) 8.87 (0.30)
8
9.83 (0.15) 
*
7.32 
(0.60)
8.20 
(0.40)
9.70 (0.17) 
*
8.16 
(0.70)
8.02 
(0.46)
8.22 
(0.38)
8.31 
(0.41)
7.88 
(0.55)
7.69 
(0.48)
10.26 (0.09) 
*
FOS
24 8.95 (0.21) 
7.13 
(0.72)
7.43 
(0.66) 8.73 (0.20)
7.29 
(0.72)
7.17 
(0.54)
7.72 
(0.60)
7.89 
(0.58)
7.61 
(0.60)
7.16 
(0.60) 9.36 (0.27)
0 7.96 (0.25)
7.02 
(0.26)
7.23 
(0.10) 8.59 (0.19)
7.66 
(0.24)
7.27 
(0.30)
7.41 
(0.17)
8.19 
(0.24)
8.04 
(0.19)
7.16 
(0.19) 9.00 (0.20)
8 8.89(0.45) 
6.87 
(0.51)
6.74 
(0.70) 8.92 (0.36)
7.89 
(0.22)
7.23 
(0.14)
7.32 
(0.30)
8.47 
(0.16)
8.06 
(0.08)
7.18 
(0.35) 9.49 (0.31)
AGP
24
9.39 (0.78) 
*
7.26 
(0.33)
7.68 
(0.83)
9.28 (0.47) 
*
7.46 
(0.30)
7.26 
(0.37)
7.89 
(0.78)
8.03 
(0.17)
7.19 
(0.35)
6.24 
(0.76) 9.84 (0.55) *
0 7.98 (0.18)
7.06 
(0.36)
7.20 
(0.46) 8.63 (0.29)
7.37 
(0.46)
7.12 
(0.46)
7.20 
(0.41)
8.38 
(0.19)
7.95 
(0.36)
7.04 
(0.40) 9.06 (0.26)
8
9.35 (0.46) 
*
7.22 
(0.44)
7.74 
(0.28)
9.36 (0.38) 
*
7.61 
(0.78)
7.00 
(0.12)
7.63 
(0.31)
8.59 
(0.23)
8.00 
(0.35)
6.94 
(0.30) 9.89 (0.33) *
AGP + AX
24 8.82 (0.28) 
6.88 
(0.76)
6.73 
(0.67) 8.82 (0.19)
6.64 
(0.75)
6.27 
(0.28)
6.47 
(0.53)
7.13 
(0.30)
6.07 
(0.45)
5.62 
(0.43) 9.25 (0.13)
0 8.53 (0.33) 8.76 
(0.13)
7.95 (0.12) 9.11 (0.04) 8.63 
(0.11)
7.60 
(0.16)
8.20 
(0.09)
9.07 
(0.04)
8.61 
(0.06)
7.75 
(0.15)
9.70 (0.03)
8 8.58 (0.32) 7.65 
(0.03)
8.55 (0.03) 9.01 (0.08) 8.25 
(0.13)
7.70 
(0.09)
8.70 
(0.06)
8.90 
(0.02)
8.54 
(0.10)
8.20 
(0.12)
9.67 (0.07)Negative for 
AX
24 8.76 (0.3) 7.90 
(0.18)
8.45 (0.13) 8.92 (0.07) 7.74 
(0.20)
7.85 
(0.10)
8.76 
(0.08)
8.54 
(0.06)
8.12 
(0.12)
7.93 
(0.12)
9.58 (0.10)
0 8.52 (0.41)
7.92 
(0.14) 8.11 (0.17) 9.13 (0.01)
8.65 
(0.06)
7.88 
(0.05)
8.28 
(0.12)
8.89 
(0.09)
8.58 
(0.03)
8.00 
(0.16) 9.67 (0.07)AX
8 9.23 (0.19) *
7.67 
(0.20) 8.84 (0.23) 9.09 (0.38)
8.32 
(0.52)
7.65 
(0.37)
8.93 
(0.24)
9.00 
(0.19)
8.61 
(0.19)
7.81 
(0.40) 9.94 (0.24) *
24
619 Table 2 Bacterial 
620 enumeration of 
621 in vitro batch culture fluid after fermentation comparing no substrate, FOS, AGP and AX. Negative control is no added carbohydrate and positive control 
622 is FOS. Values are mean log10 bacterial numbers/mL found using flow FISH. One-way AVONA was applied to the data to test the main interaction between 
623 treatments. Values in brackets are SEM. Significant difference between treatments and relevant negative control are denoted * p= 0.05 (F-test)
24 9.84 (0.09) *
8.08 
(0.22) 8.55 (0.44) 9.57 (0.18) *
8.42 
(0.40)
8.45 
(0.53)
8.63 
(0.44) 9.06(0.17)
8.26 
(0.20) 8.11 0.42) 10.29 (0.05) *
25
624
